80 FR 71807 - Board of Scientific Counselors, National Center for Injury Prevention and Control: Notice of Charter Renewal

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 80, Issue 221 (November 17, 2015)

Page Range		71807-71808
FR Document		2015-29257

Federal Register, Volume 80 Issue 221 (Tuesday, November 17, 2015)

[Federal Register Volume 80, Number 221 (Tuesday, November 17, 2015)]
[Notices]
[Pages 71807-71808]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-29257]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Injury 
Prevention and Control: Notice of Charter Renewal

    This gives notice under the Federal Advisory Committee Act (Pub. L. 
92-463) of October 6, 1972, that the Board of Scientific Counselors, 
National Center for Injury Prevention and Control, Centers for Disease 
Control and Prevention (CDC), Department of Health and Human Services 
(HHS), has been renewed for a 2-year period through November 5, 2017.
    For information, contact Gwendolyn Cattledge, Ph.D., Designated 
Federal Officer, Board of Scientific Counselors, National Center for 
Injury Prevention and Control, CDC, HHS, 1600 Clifton Road NE., M/S 
F63, Atlanta, Georgia 30329-4027, Telephone 770/488-4655.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and

[[Page 71808]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-29257 Filed 11-16-15; 8:45 am]
 BILLING CODE 4163-18-P

Federal Register / Vol. 80, No. 221 / Tuesday, November 17, 2015 / Notices 71807

medication therapy and viral load how and if the model program improves program activities, will be collected by
suppression. patient outcomes through improved program. Qualitative data will be
On May 16, 2014 OMB approved the communication and collaboration gathered from program staff through in-
collection of standardized information between patients’ clinical providers and person or telephone interviews and
from ten project sites over the three-year pharmacists. The staff communication through a questionnaire to program
project period and one retrospective questionnaire for medical providers will pharmacy staff and a separate
data collection during the first year of be administered twice to program clinic questionnaire to program clinic staff.
the three-year project period. The staff. The staff communication The data collection will allow CDC to
retrospective data collection will questionnaire for medical providers is
conduct continuous program
provide information about clients’ different from the previously improved
performance monitoring which includes
baseline characteristics prior to staff communication questionnaire; the
participation in the model program identification of barriers to program
staff communication questionnaire for
which is needed to compare outcomes implementation, solutions to those
medical providers will be administered
before and after program barriers, and documentation of client
to program clinic staff whereas the staff
implementation. On August 17, 2015 health outcomes. Performance
communication questionnaire will be
OMB approved the conduct of key monitoring will allow the model
administered to program pharmacy staff.
informant interviews with program Pharmacy, laboratory, and medical program to be adjusted, as needed, in
clinic and pharmacy staff in order to data will be collected through order to develop a final implementation
evaluate the program processes, abstraction of all participant clients’ model that is self-sustaining and which
administration of a staff communication pharmacy and medical records. can be used to establish similar
questionnaire, and OMB approved the Pharmacy, laboratory and medical data collaborations in a variety of clinical
collection of time and cost data to be are needed to monitor retention in care, settings. Collection of cost data will
used to estimate the cost of the model adherence to therapy, viral load allow for the cost of the program to be
program. suppression and other health outcomes. estimated.
CDC seeks approval to administer a Program specific data, such as the There is no cost to participants other
staff communication questionnaire for number of MTM elements completed than their time. The total estimated
medical providers in order to determine per project site and time spent on annualized burden hours are 6,043.

ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of
Number of burden per Total burden
Type of respondent Form name responses per
respondents response (in hours)
respondent (in hours)

Clinic Data Manager ......................... Project clinic characteristics form .... 10 3 30/60 15
Pharmacist ........................................ Project pharmacy characteristics 10 3 30/60 15
form.
Clinic Data Manager ......................... *Patient Demographic Information 10 100 5/60 83
form.
Clinic Data Manager ......................... *Initial patient information form ........ 10 100 1 1,000
Clinic Data Manager ......................... Quarterly patient information form ... 10 400 30/60 2,000
Pharmacist ........................................ Pharmacy record abstraction form ... 10 400 30/60 2,000
Key informants .................................. Interviewer data collection work- 60 2 30/60 60
sheet.
Project staff (pharmacists) ................ Staff communication questionnaire .. 30 2 30/60 30
Project staff (medical providers) ....... Staff communication questionnaire 40 2 30/60 40
for medical providers.
Clinic staff ......................................... Clinic cost form ................................ 20 2 10 400
Pharmacy staff .................................. Pharmacy cost form ......................... 20 2 10 400

Total ........................................... ........................................................... ........................ ........................ ........................ 6,043

Leroy A. Richardson, DEPARTMENT OF HEALTH AND and Human Services (HHS), has been
Chief, Information Collection Review Office, HUMAN SERVICES renewed for a 2-year period through
Office of Scientific Integrity, Office of the November 5, 2017.
Associate Director for Science, Office of the Centers for Disease Control and For information, contact Gwendolyn
Director, Centers for Disease Control and Prevention Cattledge, Ph.D., Designated Federal
Prevention. Officer, Board of Scientific Counselors,
[FR Doc. 2015–29274 Filed 11–16–15; 8:45 am] Board of Scientific Counselors, National Center for Injury Prevention
BILLING CODE 4163–18–P National Center for Injury Prevention and Control, CDC, HHS, 1600 Clifton
and Control: Notice of Charter Renewal Road NE., M/S F63, Atlanta, Georgia
mstockstill on DSK4VPTVN1PROD with NOTICES

30329–4027, Telephone 770/488–4655.
This gives notice under the Federal The Director, Management Analysis
Advisory Committee Act (Pub. L. 92– and Services Office, has been delegated
463) of October 6, 1972, that the Board the authority to sign Federal Register
of Scientific Counselors, National notices pertaining to announcements of
Center for Injury Prevention and meetings and other committee
Control, Centers for Disease Control and management activities, for both the
Prevention (CDC), Department of Health Centers for Disease Control and

VerDate Sep<11>2014 18:14 Nov 16, 2015 Jkt 238001 PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 E:\FR\FM\17NON1.SGM 17NON1

71808 Federal Register / Vol. 80, No. 221 / Tuesday, November 17, 2015 / Notices

Prevention and the Agency for Toxic decisions are made objectively and Agency, in collaboration with HHS and
Substances and Disease Registry. based upon the highest quality of other partners.
Elaine L. Baker,
scientific data; (8) provides technical
James Seligman,
expertise, education, and training to
Director, Management Analysis and Services Acting Chief Operating Officer, Centers for
Office, Centers for Disease Control and domestic and international partners; (9) Disease Control and Prevention.
Prevention. provides leadership to internal and
[FR Doc. 2015–29282 Filed 11–16–15; 8:45 am]
[FR Doc. 2015–29257 Filed 11–16–15; 8:45 am] external partners for establishing and
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P maintaining immunization, and other
prevention and control programs; (10)
develops, implements, and evaluates DEPARTMENT OF HEALTH AND
DEPARTMENT OF HEALTH AND domestic and international public HUMAN SERVICES
HUMAN SERVICES health policies; (11) communicates
information to increase awareness, Centers for Disease Control and
Centers for Disease Control and knowledge, and understanding of public Prevention
Prevention health issues domestically and
internationally, and to promote effective Board of Scientific Counselors, Office
Statement of Organization, Functions, of Infectious Diseases (BSC, OID)
and Delegations of Authority immunization programs; (12) aligns the
national center focus with the overall
Part C (Centers for Disease Control In accordance with section 10(a)(2) of
strategic goals of CDC; (13) synchronizes
and Prevention) of the Statement of the Federal Advisory Committee Act
all aspects of CDC’s pandemic influenza
Organization, Functions, and (Pub. L. 92–463), the Centers for Disease
preparedness and response from Control and Prevention (CDC),
Delegations of Authority of the strategy through implementation and
Department of Health and Human announces the following meeting of the
evaluation; and (14) implements, aforementioned committee:
Services (45 FR 67772–76, dated coordinates, and evaluates programs
October 14, 1980, and corrected at 45 FR across NCIRD, Office of Infectious Time and Date:
69296, October 20, 1980, as amended 8:30 a.m.–5:00 p.m., EST, December 9, 2015
Diseases (OID), and CDC to optimize 8:00 a.m.–12:00 p.m., EST, December 10,
most recently at 80 FR 58479–58485,
public health impact. 2015
dated September 29, 2015) is amended
to reflect the reorganization of the Delete in its entirety the title and Place: CDC, Global Communications Center,
National Center for Immunization and function statements for the Office of 1600 Clifton Road, NE., Building 19,
Respiratory Diseases, and the Office of Laboratory Science (CVG14). Auditorium B3, Atlanta, Georgia 30333.
Infectious Diseases, Centers for Disease Status: The meeting is open to the public,
After the Office of Science and limited only by the space available.
Control and Prevention. Integrated Programs (CVG17) insert the
Section C–B, Organization and Purpose: The BSC, OID, provides advice
following: and guidance to the Secretary, Department of
Functions, is hereby amended as
Influenza Coordination Unit (CVG18). Health and Human Services; the Director,
follows:
The mission of the Influenza CDC; the Director, OID; and the Directors of
Delete in its entirety the title and
the National Center for Immunization and
function statements for the Influenza Coordination Unit (ICU) is to
Respiratory Diseases, the National Center for
Coordination Unit (CVA4). synchronize all aspects of CDC’s Emerging and Zoonotic Infectious Diseases,
Delete in its entirety the title and pandemic influenza preparedness and and the National Center for HIV/AIDS, Viral
function statements for the National response from strategy through Hepatitis, STD, and TB Prevention, CDC, in
Center for Immunization and implementation and evaluation. In the following areas: Strategies, goals, and
Respiratory Diseases (CVG) and insert carrying out its mission, the ICU: (1) priorities for programs; research within the
the following: Serves as the principal advisor to the national centers; and overall strategic
National Center for Immunization CDC Director on pandemic influenza direction and focus of OID and the national
and Respiratory Diseases (CVG). The preparedness and response activities, centers.
National Center for Immunization and Matters for Discussion: The meeting will
assisting the Director in formulating and include reports from the Board’s Food Safety
Respiratory Diseases (NCIRD) prevents communicating strategic pandemic
disease, disability, and death through Modernization Act Surveillance Working
initiatives and policies; (2) provides Group and Infectious Disease Laboratory
immunization and by control of
strategic leadership for CDC in the areas Working Group; brief updates on selected
respiratory and related diseases. In activities of CDC’s infectious disease national
of pandemic preparedness and
carrying out its mission, NCIRD: (1) centers; and updates and focused discussions
Provides leadership, expertise, and response, including setting priorities
and promoting science, policies, and on prevention of Legionella disease and
service in laboratory and efforts to better understand and address
epidemiological sciences, and in programs related to pandemic influenza;
environmental factors contributing to
immunization program delivery; (2) (3) strategically manages a budget and infectious disease outbreaks.
conducts applied research on disease allocates funds across the agency to Agenda items are subject to change as
prevention and control; (3) translates ensure appropriate resources for high priorities dictate.
research findings into public health priority areas; and (4) conducts ongoing Contact Person for More Information:
policies and practices; (4) provides evaluation and adjustment of pandemic Robin Moseley, M.A.T., Designated Federal
preparedness and response activities, in Officer, OID, CDC, 1600 Clifton Road NE.,
mstockstill on DSK4VPTVN1PROD with NOTICES

diagnostic and reference laboratory
coordination with the National Mailstop D10, Atlanta, Georgia 30333,
services to relevant partners; (5)
Response Framework and other Telephone: (404) 639–4461.
conducts surveillance and research to The Director, Management Analysis and
determine disease distribution, emergency preparedness guidance, to Services Office has been delegated the
determinants, and burden nationally ensure optimal public health authority to sign Federal Register notices
and internationally; (6) responds to effectiveness and efficient use of human pertaining to announcements of meetings and
disease outbreaks domestically and and fiscal resources by developing and other committee management activities, for
abroad; (7) ensures that public health leading an exercise program for the both the Centers for Disease Control and

VerDate Sep<11>2014 18:14 Nov 16, 2015 Jkt 238001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\17NON1.SGM 17NON1

Document Created: 2015-12-14 14:00:04
Document Modified: 2015-12-14 14:00:04

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
FR Citation		80 FR 71807

80 FR 71807 - Board of Scientific Counselors, National Center for Injury Prevention and Control: Notice of Charter Renewal

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 80, Issue 221 (November 17, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention